"My first focus was then to start from the basis and set up the strategic tools we were lacking of."
In Conversation
Across the board we are industry agnostic, meaning that whatever industry comes to us looking for support, we are happy to help
"Legal reforms are done with, implementation is now the name of the game."
"The true core of our company has always been its scientific expertise."
Interview: Cecilia Pang Wai-bing – Biotechnology Director, Innovation and Technology Commission (ITC), Hong Kong

"We were a latecomer to the industry because we do not have a large pharma industry base, but we are very strong in academic research, especially…
"The Colombian healthcare system and the services available here are amongst the best in the region and we are extremely optimistic about working to service the…
"We host the headquarters for the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the National Cancer Institute (NCI), among others."
Interview: Christa Wirthumer-Hoche – Head, Austrian Medicines and Medical Devices Agency (AGES); Chairwoman, EMA Management Board, Austria

"Austria is a rather small country with a mid-sized agency in terms of staff members, but we are a very active partner in all the scientific…
"[Colombia] is a market of political and economic stability that has been growing and will continue experiencing growth."
"The diverse nature of this region is conducive to the continuous rise of new challenges."
"[The Colombian medical device market] is an estimated 1.2 billion USD market that will register five year compounded annual growth of approximately eight percent in local currency…
"In Ukraine, Takeda’s commitment to patients goes beyond medicine access."